Skip to main content

Type 1 Diabetes News

Type 1 Diabetes is a chronic condition in which your body loses the ability to produce insulin, which is necessary for most cells to convert food into energy and regulate blood sugar levels. 

Experts and innovators from all corners gathered to share the latest in new technology and treatments for people with diabetes, focusing on improving CGM and outcomes...
ADA is around the corner, and there’s going to be exciting updates on diabetes drugs and therapy, devices, big picture questions, #beyondA1C, and advocacy; stay tuned!
Learn more about DiabetesMine D-Data highlights, implantable CGM Eversense used in adolescents, and Sugar.IQ real-world data
Limited launch in May-July. No receiver! Smartphone-only display on Apple iOS devices. Plus, the new “personal diabetes assistant,” Sugar.IQ with Watson
Recruiting now! This major study will support FDA submission of Tandem’s t:slim X2 with Control-IQ and Dexcom G6 in people with type 1 ages 14 and up; includes automatic...
Low-cost education services can help you learn new skills to eat well, stay active, and monitor blood sugar levels
FDA clearance and limited US launch expected in the second half of 2018. Dash adds improved user experience, Bluetooth, smartphone viewing, remote monitoring
Smart Patients and diaTribe are partnering to offer an easy and supportive platform to talk about diabetes
Medtronic hopes to launch at least 10 products over the next two years: new CGM and apps, 670G pump with Bluetooth, AI, and more!
Read about combo drug Xultophy, Toujeo vs. Tresiba, diabetes apps, the do-it-yourself community, FreeStyle Libre real-world data, and more!
The upcoming Basal-IQ predictive low glucose suspend system (summer 2018 launch expected), plus plans for Control-IQ hybrid closed loop, a mobile app, and the t:sport “...
Learn more about the All of Us Research Program, a massive national effort to collect individual health data to support precision medicine research
Delays caused by sensor shortages largely resolved; MiniMed 670G now ships as soon as insurance is approved; a new assistance program to help with upfront costs
An app uses blood sugar readings and other diabetes information to provide personalized guidance to workouts, along with exercise videos specifically for people with...
Limited US launch beginning in second half of this year, with full launch in early 2019; Dash PDM Handheld will be free with purchase of pods
Using time-in-range to assess risk for complications, Omnipod Horizon Closed Loop, Bihormonal closed loop (insulin + Pramlintide), SGLT-2 oral drug for type 1, and more!
Geisinger’s Fresh Food Farmacy provides a “prescription” for healthy food to people with type 2 diabetes who are food insecure; plus, a Q&A with Geisinger
The smart insulin pen’s Android app is expected to launch later this year in the US; a Europe launch is expected in 2019. Plus, learn about four other smart pens/caps in...
At the Lilly Diabetes Bloggers Summit, diaTribe got to hold a prototype of Lilly’s new, disk-like pump, which will integrate with Dexcom G6 CGM in a hybrid-closed loop...
The S-ICD is an FDA-approved device that can prevent sudden cardiac arrest; this trial is testing it in people with diabetes who’ve had prior heart attacks with...

Pages